<?xml version="1.0" encoding="UTF-8"?>
<p id="par0020">The novel coronavirus (COVID-19) outbreak has turned into a global pandemic, causing 810,492 deaths and 23,518,343 infected cases in 216 countries, areas, or territories as of August 25, 2020 [
 <xref rid="bib0005" ref-type="bibr">1</xref>], which is an irreparable loss. Unfortunately, despite considerable advancements in the field of antiviral drug discovery over the past years [
 <xref rid="bib0010" ref-type="bibr">2</xref>], there is still no approved drug or vaccine that can treat this disease [
 <xref rid="bib0015" ref-type="bibr">3</xref>]. Likewise, there are over 200 other infectious diseases [
 <xref rid="bib0010" ref-type="bibr">2</xref>]. In the last two decades, there have been a number of pathogenic viruses that have caused public health emergencies and socioeconomic losses (
 <xref rid="fig0005" ref-type="fig">Fig. 1</xref> a). For instance, the severe acute respiratory syndrome (SARS) outbreak in 2003 induced 774 deaths and 8096 infection cases [
 <xref rid="bib0020" ref-type="bibr">4</xref>], and its economic cost was estimated to be over $US 40 billion [
 <xref rid="bib0025" ref-type="bibr">5</xref>]. Similarly, approximately 37.9 million people worldwide suffered from the human immunodeficiency virus (HIV) around the end of 2018 [
 <xref rid="bib0030" ref-type="bibr">6</xref>], leading to an increasing healthcare burden in low-income countries.
</p>
